International Cooperative Phase III Trial of the HIT-HGG Study Group (HIT-HGG-2013)

NCT03243461 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

167

Enrollment

OTHER

Sponsor class

Conditions

Glioblastoma WHO Grade IV
Diffuse Midline Glioma Histone 3 K27M WHO Grade IV
Anaplastic Astrocytoma WHO Grade III
Diffuse Intrinsic Pontine Glioma
Gliomatosis Cerebri

Interventions

DRUG: Temozolomide + Valproic Acid

Sponsor

University of Göttingen

Collaborators

[object Object]
[object Object]